A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department

Medical Journal of Australia

Volumn 187, Issue 10, 2007, Pages 567-570

  Batmanian, Julia J ^a   Lam, Meeyin ^a   Matthews, Caitlin ^a   Finckh, Andrew ^a   Duffy, Martin ^a   Wright, Robert ^a   Brew, Bruce J ^a,b   Markus, Romesh ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ACUTE DISEASE; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CARE; FEMALE; FIBRINOLYTIC THERAPY; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET AGE; RANKIN SCALE; SYMPTOM; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; BRAIN ISCHEMIA; EMERGENCY HEALTH SERVICE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; STROKE; THEORETICAL MODEL; TIME;

AGED; BRAIN ISCHEMIA; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 38449113763     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb01418.x     Document Type: Article

References (18)

1. Hankey GJ. Transient ischaemic attacks and stroke. Med J Aust 2000; 172: 394-400.
2. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995; 333: 1581-1587.
3. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004; 61: 1066-1070.
4. Qureshi AI, Kirmani JF, Sayed MA, et al. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology 2005; 64: 2115-2120.
5. Duffy BK, Phillips PA, Davis SM, et al. Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust 2003; 178: 318-323.
6. Hoffman JR. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little. Med J Aust 2003; 179: 333-334.
7. Szoeke CE, Parsons MW, Butcher KS, et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 2003; 178: 324-328.
8. Faux S, Lam M, Fuller K, Markus R. Combined stroke database and electronic discharge summary: The St Vincent's Hospital (Sydney) Prospective Stroke Registry [abstract]. Intern Med J 2005; 35: A15.
9. Adams H Jr, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
10. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
11. Hill MD, Barber PA, Takahashi J, et al. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000; 162: 1281-1284.
12. Katzan IL, Hammer MD, Hixson ED, et al. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004; 61: 346-350.
13. Koennecke HC, Nohr R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 2001; 32: 1074-1078.
14. The ATLANTIS ECASS and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
15. Adams H, Adams R, Del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916-923.
16. Hill MD, Buchan AM, for The Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005; 172: 1307-1312.
17. California Acute Stroke Pilot Registry Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005; 64: 654-659.
18. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000; 55: 1649-1655.